Related Experiment Video
Updated: Jan 12, 2026

07:10
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
14.7K
CD4-Dependent Modulation of HIV-1 Entry by LY6E
Jingyou Yu1,2, Chen Liang3,4, Shan-Lu Liu5,6,2,7
1Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA.
Journal of Virology
|January 25, 2019
Summary
Lymphocyte antigen 6E (LY6E) differentially affects HIV-1 infection. In low-CD4 cells, LY6E inhibits infection by downregulating CD4, while in high-CD4 cells, it promotes infection.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Interferon-inducible genes (ISGs) play complex roles in viral infections, with some promoting and others inhibiting viral replication.
- Lymphocyte antigen 6E (LY6E) is an ISG known to modulate viral infections, including HIV-1, in a cell type-dependent manner.
- Previous studies indicated LY6E promotes HIV-1 infection in high-CD4-expressing cells like PBMCs and SupT1 cells.
Purpose of the Study:
- To investigate the role of LY6E in HIV-1 infection in low-CD4-expressing cells.
- To elucidate the mechanism by which LY6E modulates HIV-1 entry and replication.
- To understand the differential impact of LY6E on HIV-1 pathogenesis based on CD4 expression levels.
Main Methods:
- Studied HIV-1 infection in Jurkat cells and human monocyte-derived macrophages (MDMs) with varying LY6E expression levels.
- Utilized gene knockdown and overexpression techniques for LY6E.
- Assessed CD4 receptor levels and internalization via cell surface staining and microscopy.
- Manipulated CD4 expression and function to confirm its role in LY6E's effects.
Main Results:
- LY6E inhibits HIV-1 entry and replication in low-CD4-expressing Jurkat cells and MDMs.
- Knockdown of LY6E increased HIV-1 infection in these cells, while overexpression inhibited it.
- LY6E downregulates cell surface CD4 by enhancing its internalization, impairing HIV-1 binding.
- Overexpression of CD4 in Jurkat cells rescued LY6E-mediated inhibition, and CD4 blockade in SupT1 cells abolished LY6E enhancement of HIV-1 entry.
Conclusions:
- LY6E exhibits opposing roles in HIV-1 infection, inhibiting it in low-CD4 cells and promoting it in high-CD4 cells.
- The differential effect is mediated by LY6E's modulation of CD4 receptor expression and function.
- These findings highlight the complex roles of ISGs in viral pathogenesis and have implications for understanding HIV-1 infection dynamics.

